Table 1.
Identification Method |
||||||
---|---|---|---|---|---|---|
Clinical Syndromea | Cases Reported | Animal Exposureb | Biochemical Methodsc |
Molecular Methodsd |
Referencese | |
SIG | SI | PSIM | ||||
Skin and soft tissue | 22 | 9 (3 animal bites) | 13 | 4 | 5 | This report and [1, 13, 20] |
Bacteremia without endocarditis | 3 | 3 | 3 | 0 | 0 | This report and [1, 7] |
Bone/joint infection | 4 | 2 | 3 | 0 | 1 | This report and [1] |
Endocarditis | 3 | 1 | 1 | 0 | 2 | [1, 8] |
Central nervous system | 2 | 0 | 1 | 1 | 0 | [1, 15] |
Sinusitis/mastoiditis | 2 | 2 | 2 | 0 | 0 | [1] |
Pneumonia | 3 | 1 | 1 | 0 | 2 | [1, 14] |
Device related | 2 | 1 | 1 | 0 | 1 | This report and [1] |
Abbreviations: MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight; SIG, Staphylococcus intermedius group; SI, Staphylococcus intermedius; PSIM, Staphylococcus pseudintermedius.
a Most severe clinical syndrome reported (ie, patient with skin infection and bacteremia, reported as bacteremia and not skin and soft tissue).
b History of animal exposure was not available in all reports.
c Includes automated and manual systems.
d Includes gene sequencing (rpoB, hsp60, 16s DNA) and MALDI-TOF.
e Multiple cases per reference.